Dentsply Sirona/$XRAY
1D1W1MYTD1Y5YMAX
Capital at risk
About Dentsply Sirona
Dentsply Sirona is one of the world's largest manufacturers of dental equipment and supplies. It is a result of a merger of equals in 2016 between Dentsply International (dental consumables and lab products) and Sirona Dental Systems (technologically advanced dental equipment). The firm's wide portfolio consists of dental consumables, lab products, CAD/CAM and imaging technology, medical devices, and specialty products in orthodontics, endodontics, and implantology. It distributes two-thirds of its dental consumables, technology, and equipment through third-party distributors. The remaining portfolio is sold to labs and offices through the firm's salesforce or directly to consumers.
- Ticker
- $XRAY
- Sector
- Health
- Primary listing
- NASDAQ
- Employees
- 14,000
- Headquarters
- Charlotte, United States
- Website
- www.dentsplysirona.com
Dentsply Sirona Metrics
BasicAdvanced
$1.9B
-
-$2.73
0.85
$0.32
6.54%
Price and volume
Market cap
$1.9B
Beta
0.85
52-week high
$14.76
52-week low
$9.36
Average daily volume
4.2M
Dividend rate
$0.32
Financial strength
Current ratio
1.627
Quick ratio
0.725
Long term debt to equity
1.543
Total debt to equity
1.711
Interest coverage (TTM)
1.70%
Profitability
EBITDA (TTM)
524
Gross margin (TTM)
49.52%
Net profit margin (TTM)
-14.99%
Operating margin (TTM)
4.86%
Effective tax rate (TTM)
-57.64%
Revenue per employee (TTM)
$260,000
Management effectiveness
Return on assets (TTM)
1.94%
Return on equity (TTM)
-33.03%
Valuation
Price to revenue (TTM)
0.536
Price to book
1.44
Price to tangible book (TTM)
-2.97
Price to free cash flow (TTM)
13.658
Free cash flow yield (TTM)
7.32%
Free cash flow per share (TTM)
0.716
Dividend yield (TTM)
3.27%
Forward dividend yield
6.54%
Growth
Revenue change (TTM)
-0.76%
Earnings per share change (TTM)
-42.61%
3-year revenue growth (CAGR)
-2.55%
10-year revenue growth (CAGR)
1.58%
3-year earnings per share growth (CAGR)
-17.08%
10-year earnings per share growth (CAGR)
2.53%
3-year dividend per share growth (CAGR)
-15.48%
10-year dividend per share growth (CAGR)
0.65%
What the Analysts think about Dentsply Sirona
Analyst ratings (Buy, Hold, Sell) for Dentsply Sirona stock.
Analyst projections of the future price of Dentsply Sirona stock.
Bulls say / Bears say
Dentsply Sirona launched Smart View-Detect, the world’s first FDA-cleared AI-enabled diagnostic aid for detecting teeth with periapical radiolucencies, boosting its digital dentistry offerings (Reuters)
The MAGNETOM Free.Max Dental Edition, a dental-dedicated MRI system co-developed with Siemens Healthineers, won FDA clearance in March 2026, expanding Dentsply Sirona’s advanced imaging portfolio (Reuters)
Dentsply Sirona and Burkhart Dental Supply announced an expanded distribution partnership to include technology equipment, enhancing market access and accelerating growth in key U.S. regions (Reuters)
Adjusted EPS for Q1 2026 missed analyst expectations, falling 39% year‐over‐year and underscoring persistent profitability challenges despite flat revenue (Reuters)
Net sales for Q2 2026 declined 4.1% year‐over‐year and constant‐currency sales fell 6.3%, reflecting ongoing demand weakness and currency headwinds in core markets (Reuters)
Form SD filed June 1, 2026 reveals Dentsply Sirona may unknowingly source 3TG minerals from sanctioned smelters and refiners in its multi‐tier supply chain, exposing the company to geopolitical and regulatory sanctions risk (Dentsply Sirona Form SD)
Data summarised monthly by Lightyear AI. Last updated on 3 Sept 2026.
Dentsply Sirona Financial Performance
Revenues and expenses
Dentsply Sirona Earnings Performance
Company profitability
Upcoming events
No upcoming events
Dentsply Sirona News
AllArticlesVideos
Funds containing Dentsply Sirona
AllEURUSDGBP
Fund name | Fund size | $XRAY weighting |
|---|---|---|
SPDR Russell 2000 US Small Cap€R2US | €4.8B | 0.07% |
SPDR S&P 400 US Mid Cap$SPY4 | $6.3B | 0.06% |
SPDR S&P 400 US Mid Cap£SPX4 | £4.7B | 0.06% |
Amundi S&P 500£500G | £6.6B | 0.04% |
iShares MSCI USA Small Cap ESG Enhanced CTB€SXRG | €2.8B | 0.03% |
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.